Diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease

Psychiatric Services

Volumn 57, Issue 5, 2006, Pages 617-619

  Lavretsky, Helen ^a   Nguyen, Lang Hai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; CLOZAPINE; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TRAZODONE; VALPROIC ACID; ZIPRASIDONE;

AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY DISORDER; BEHAVIOR DISORDER; CAREGIVER; CEREBROVASCULAR DISEASE; DEMENTIA; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; PSYCHOSIS; REVIEW; SIDE EFFECT; ARTICLE; BEHAVIOR; FORECASTING; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; CHOLINESTERASE INHIBITORS; FORECASTING; HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 33646456641     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.57.5.617     Document Type: Review

References (17)

1. The Expert Consensus Panel for Agitation in Dementia: treatment of agitation in older persons with dementia. Postgraduate Medicine 103(Apr special issue):1-88, 1998
2. Teri L, Logsdon RG, Uomoto J, et al: Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology: Series B, Psychological Sciences and Social Sciences 4:159-166, 1997
3. Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 293:596-608, 2005
4. Lavretsky H: Therapy of depression in dementia. Expert Review of Neurotherapeutics 3(5):89-97, 2003
5. Schneider LS, Pollock VE, Lyness SA: A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society 38:553-563, 1990
6. Byerly MJ, Weber MT, Brooks DL, et al: Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs and Aging 18:45-61, 2001
7. Katz IR, Jeste DV, Mintzer JE, et al: Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Journal of Clinical Psychiatry 60:107-115, 1999
8. Street JS, Clark WS, Cannon KS, et al: Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities. Archives of General Psychiatry 57:968-976, 2000
9. Schneider LS, Tariot PN, Lyketsos CG, et al: National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journal of Geriatric Psychiatry 9:346-360, 2001
10. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry 14:191-210, 2006
11. Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294:1934-1943, 2005
12. Wang PS, Schneeweiss S, Avorn J, et al: Risk of death in elderly users of conventional vs atypical antipsychotic medications. New England Journal of Medicine 353:2335-2341, 2005
13. Sultzer DL, Gray KF, Gunay I, et al: Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? Journal of the American Geriatrics Society 49:1294-1300, 2001
14. Trinh N-H, Hoblyn J, Mohanty S, et al: Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer's disease. JAMA 289:210-216, 2003
15. Meehan KM, Wang H, David SR, et al: Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 26:494-504, 2002
16. Lavretsky H, Kumar A: Clinically significant non-major depression: old concepts, new insights. American Journal of Geriatric Psychiatry 10:239-255, 2002
17. Kaufer DI: Pharmacological therapy of dementia with Lewy bodies. Journal of Geriatric Psychiatry and Neurology 15:224-232, 2002